Skip to main content
. 2021 Jun 11;12:665407. doi: 10.3389/fimmu.2021.665407

Figure 7.

Figure 7

Validation of the prognostic value of the key immune-related gene signature based on a group of 36 frozen tissues from early stage LUSC patients. (A) The distribution of risk score and survival status. (B) Distribution of specific gene expression based on risk score. (C) ROC curves of these key genes to predict death risk at 3 and 5 years. (D) Comparison of overall survival of all patients with early stage LUSC between high risk and low risk. (E, F) Kaplan–Meier curves of patients with stage I and stage II LUSC based on risk score.